Literature DB >> 31303129

Downregulation of RPS15A by miR-29a-3p attenuates cell proliferation in colorectal carcinoma.

Zilei Zheng1, Haitao Cui2, Yi Wang2, Weilong Yao3.   

Abstract

miR-29a-3p has been reported to function as a tumor suppressor in several cancers. However, the biological function role of miR-29a-3p in colorectal carcinoma (CRC) has not been well investigated. In this study, we found that miR-29a-3p was at lower level expression in CRC tissues and cell lines. Experimental up-regulation miR-29a-3p with mimic could inhibit cell proliferation, but induced cell cycle arrest at G0/G1 phase and apoptosis in CRC cells. MiR-29a-3p overexpression significantly down-regulated the expression levels of CDK4, Cyclin D1, and Bax, but up-regulated the expression levels of p21 and Bcl-2 in DLD-1 cells. Moreover, ribosomal protein S15A (RPS15A) was predicted and confirmed as a direct target gene of miR-29a-3p. Furthermore, restoration of RPS15A could rescue the phenotypic changes caused by miR-29a-3p. The findings demonstrate miR-29a-3p inhibits CRC cell function possibly by targeting RPS15A, which might be exploited therapeutically in CRC.

Entities:  

Keywords:  Colorectal carcinoma; RPS15A; apoptosis; cell cycle; miR-29a-3p

Mesh:

Substances:

Year:  2019        PMID: 31303129     DOI: 10.1080/09168451.2019.1637712

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  5 in total

1.  miR-29a-3p mitigates the development of osteosarcoma through modulating IGF1 mediated PI3k/Akt/FOXO3 pathway by activating autophagy.

Authors:  Song Qi; Li Xu; Yongyuan Han; Hongkun Chen; Anyuan Cheng
Journal:  Cell Cycle       Date:  2022-05-31       Impact factor: 5.173

Review 2.  A review on the role of cyclin dependent kinases in cancers.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Peixin Dong; Nikolaus Gassler; Mohammad Taheri; Aria Baniahmad; Nader Akbari Dilmaghani
Journal:  Cancer Cell Int       Date:  2022-10-20       Impact factor: 6.429

3.  Bioinformatic gene analysis for potential biomarkers and therapeutic targets of diabetic nephropathy associated renal cell carcinoma.

Authors:  Yunze Dong; Wei Zhai; Yunfei Xu
Journal:  Transl Androl Urol       Date:  2020-12

4.  miR-29a-3p inhibits the malignant characteristics of non-small cell lung cancer cells by reducing the activity of the Wnt/β-catenin signaling pathway.

Authors:  Kang Zhang; Xiaoliang Han; Wenbin Hu; Chao Su; Binjun He
Journal:  Oncol Lett       Date:  2022-09-12       Impact factor: 3.111

5.  miR-29a-3p inhibits endometrial cancer cell proliferation, migration and invasion by targeting VEGFA/CD C42/PAK1.

Authors:  Aizhi Geng; Lin Luo; Fengyun Ren; Ling Zhang; Haiying Zhou; Xue Gao
Journal:  BMC Cancer       Date:  2021-07-21       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.